Corporate GovernanceAug 11, 2026, 05:02 PM
Imunon Executive Officers Opt for Stock-Based Compensation
AI Summary
Imunon, Inc.'s Compensation Committee and Board of Directors have approved new compensatory programs for certain executive officers. These programs allow executives to elect to receive a percentage of their base salary in common stock. In addition to the salary conversion, the executives will also receive grants of additional common stock.
Key Highlights
- Stacy Lindborg, President and CEO, can elect to receive up to 50% of her base salary in common stock.
- Lindborg will receive additional shares: 35% for August 14 and 17.5% for August 28-September 25, 2026 pay dates.
- Michael Tardugno, Executive Chairman, can elect to receive up to 100% of his base salary in common stock.
- Tardugno will receive additional shares: 40% for August 14 and 20% for August 28-September 25, 2026 pay dates.
- Douglas Faller, Chief Medical Officer, can elect to receive up to 40% of his base salary in common stock.
- Faller will receive additional shares: 15% for July 31-September 25, 2026 pay dates.
- Shares for Lindborg and Tardugno are exempt from registration under Section 4(a)(2) of the Securities Act.
- Shares for Faller will be issued pursuant to the Imunon, Inc. 2018 Stock Incentive Plan.
Price Impact
More from IMNN